14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
FRO vs OSG: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FRO vs OSG. Trailing 12-month operating profitability (FRO 50.0% vs OSG N/A) and valuation multiples (FRO 7.3x vs OSG N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ FRO vs OSG Key Questions & Quantitative Answers
As of Nov 16, 2026, Frontline Plc (FRO) is the stronger overall head-to-head candidate over OSG (OSG) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). FRO carries a Unified Composite Score of 59.2/100 (HOLD) at $45.44 (7.3x Forward P/E, 50.0% operating margin), whereas OSG carries 42.5/100 (HOLD) at $5.32 (N/M Forward P/E, N/A operating margin). Technically, FRO sits in a Neutral phase (RSI 39.7, CONSOLIDATION options structure) and OSG sits in a Markup phase (RSI 60.2, UNCLASSIFIED options structure).
FRO leads the Growth & Scale pillar: FRO posts +96.5% YoY revenue growth and +750.1% YoY earnings growth on $2.71B TTM revenue (63.0% gross margin, 50.0% operating margin), compared with OSG at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, FRO generates $2.71B in USD-normalized revenue versus N/A for OSG. In operating R&D and SG&A reinvestment, FRO deploys 13.0% of Rev ($353M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for OSG.
FRO screens cheaper on headline valuation multiples. FRO trades at 7.3x Forward P/E, 7.0x Trailing P/E, 5.58x PEG, and 4.6x EV/Revenue (25.4% FCF margin), whereas OSG trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against FRO (53.8% ROE) versus OSG (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, FRO carries 77.8% implied volatility (22nd %ile, Compressed (<25th %ile)), a 0.51x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.56β · 60% Vol realized risk). By comparison, OSG carries 58.1% implied volatility (42nd %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.19β · 44% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.